Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Vicore Pharma Holding AB

Closing information (x1000 DKK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 240 More Arrow 318 More Arrow 1,864
Earnings before taxes -209,110 More Arrow -192,990 Less Arrow -215,765
EBITDA -213,693 More Arrow -192,029 Less Arrow -211,755
Total assets 334,385 Less Arrow 225,868 More Arrow 328,058
Current assets 332,879 Less Arrow 180,283 More Arrow 274,805
Current liabilities 26,048 More Arrow 30,934 More Arrow 47,678
Equity capital 305,873 Less Arrow 193,175 More Arrow 278,721
- share capital 37,520 Less Arrow 27,347 Less Arrow 26,089
Employees (average) 25 Less Arrow 21 Less Arrow 16

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 91.5% Less Arrow 85.5% Less Arrow 85.0%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -62.5% Less Arrow -85.3% More Arrow -65.2%
Current ratio 1277.9% Less Arrow 582.8% Less Arrow 576.4%
Return on equity (ROE) -68.4% Less Arrow -99.9% More Arrow -77.4%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 4 More Arrow 5 Less Arrow 3
Chg. No. of employees % 19% More Arrow 31% Less Arrow 23%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.